Lecture 10 - Bronchodilators Flashcards
Side effects of corticosteroids
- not common when using less than 1000 ug/day
- oropharyngeal thrush
- dysphonia
- immunosuppression, adrenal suppression in response to stress, osteroporosis, muscle wasting, hyperglycemia, cataracts, brusing, moon face, hyperextension, buffalo hump
Corticosteroids improve lung function: study
- it takes several weeks for the treatment to start having an effect
- the key is to combine a short acting with a long acting reliever
- comes back at normal after 8 weeks - but patients have to keep going
- low values are generally in the morning, low values in the evening
Corticosteroids MOA
- Nuclear receptors have to cross into cells or ligand activated transcription factors
- not found in membranes
- regulate gene transcription - steroid and thyroid hormones
- can both increase and decrease gene transcription
- increase: Annexin-1, b adrenergic receptor
- decreases- cytokines (inflammtation(
Low dose corticosteroid MOA
- repress gene transcription by trans-repression.
- binds the glucocorticoid receptor then binds to CBP and then interact with HDAC2 -> winds up the genes and shuts down transcription of inflammatory genes
High dose corticosteroid MOA
- cis repression: negative GRE
- trans activation: GRE, anti-inflammatory
- forms homodimer which migrates to nucleus
Corticosteroid resistance
- asthmatic people are more likely to smoke
- non-smokers: improvement with use of glucocorticosteroids
- in smokers: increase free radicalproduction and inflammation leads to no benefits from glucocorticosteroids
Mechanism of smoking and decrease effectiveness of glucocorticosteroids
- cigarette smoke and inflammation leads to increase free radical and NO which combine to form Peroxynitrite, which activates PI3Kdelta
- this phosphorylates and inactivates HDAC2 -> winds up and represses transcription of inflammatory genes
- low dose might be a powerful antioxydant
Diagnosis of asthma
- history
- physical examination
- Consider other diagnoses
- documenting variable airflow limitation
Drug target ASM and/or inflammation
- Smooth muscle has a b2 adrenoceptor on it - for people with asthma, number of most cells in smooth muscle - increases contraction via histamine
- epithelium - other target for b2 receptors - mucocilliary transport very weak - more obstruction
ANS control
- sympathetic NS: open up airway via activation of adrenal glands and release of adrenaline - acts on b2
- Parasympathetic NS: via vagus nerve
- short post ganglionic nerve fiber in airway - releases Ach which binds M3AChR - release of calcium in cells in smooth muscle - contraction
- IgE in mast cel when cross link cause increase calcium in mast cells - release of Histamine - bing H1R on smooth muscle cell - contraction
SNS - special ganglia in the adrenal medulla
- sympathetic activation leads to Ach release from presynaptic nerve which act on nicotinic ACh receptors of chromaffin cells in medulla to cause release of noradrenaline and adrenaline
B adrenoceptor agonist
- SABA: adrenaline, salbutamol, albuerol, fenoterol, terbutaline sulphate
- LABA: salmeterol, formoterol
- UltraLABA: indacaterol, vilanterol
Anti-cholinergic drigs
- SAMA: ipratropium bromide
- LAMA: tiotropium bromide
Antileukotrienes
- act on cysLT1 antagonists - promote contraction nearly equally effective as corticosteroids
Phosphodiesterase inhibitors
- increase cAMP t1/2
- intracellular mediator that helps reduce calcium
- selctive PDE4: roflumilast: COPD
Net contraction = contraction - relaxation
1) Contraction pathway
- Hist - H1R
- AChh - M3AchR
- LT - CysLT1
- all constitituve active and activate By - activate PLC which produces DAG + IP3 increases calcium
2) Relaxation pathway
- Adrenaline receptor constitutively active - Activates Gas - increase CAMP which inhibits MLCKCyt - decrease calcium, decrease contraction
Summary of b2 adrenoceptor activation
- smooth muscle relaxation (inhibition of contraction)
- increased ciliary beat frequency
- inhibition of mast cell activation: decrease mediator release, desensitization
Effects of salbutamol
- prevents asthma attack before exercise
- decrease airway resistance via b2
- increase b1 activation - increase HR
Asthma attack classification
- Mild - speak in whole sentences
- Severe: speech not in full sentences, O2 saturation (90-94%)
- life threatening (
Adverse effects of b2 agonists
- tremor
- increased HR palpitations (b1)
- SK vasoduilation and relex tachycardia
- tolerance of b2 adrenergic agonist
- masking of signs and symptoms of asthma
- increase muscle mass
Acute effect of b2 agonists
- Hyperglycemia (B3)
- Hypokalaemia
- Hypomagnesemia - cramping
Study on SABA and LABA
- SABA use alone increases airflow variability indicating poor asthma control and promotes unstable airway function leading to precipitate a severe asthma attach
- need to combine with LABA
- regular short acting agonist therapy should not be used to treat asthma
COPD
- small airway disease
- alveolar destruction
- comorbidities
COPD bronchodilators
- short acting reliever meds: SABA or SAMA
- symptom relief: LAMA and/or LABA
- exacerbation prevention
- for severe COPD also consider low dose theophylline
- Newer treatment includes ultraLABA/LAMA